Medline Inc.
MDLN
$41.46
$0.390.95%
NASDAQ
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/28/2025 | ||
|---|---|---|---|---|---|
| Revenue | 11.87% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 11.87% | -- | -- | -- | |
| Cost of Revenue | 13.05% | -- | -- | -- | |
| Gross Profit | 8.69% | -- | -- | -- | |
| SG&A Expenses | 11.06% | -- | -- | -- | |
| Depreciation & Amortization | 2.77% | -- | -- | -- | |
| Other Operating Expenses | 74.03% | -- | -- | -- | |
| Total Operating Expenses | 12.50% | -- | -- | -- | |
| Operating Income | 4.85% | -- | -- | -- | |
| Income Before Tax | 1.12% | -- | -- | -- | |
| Income Tax Expenses | 108.70% | -- | -- | -- | |
| Earnings from Continuing Operations | -3.00% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -2.84% | -- | -- | -- | |
| EBIT | 4.85% | -- | -- | -- | |
| EBITDA | 4.42% | -- | -- | -- | |
| EPS Basic | 1,584.85% | -- | -- | -- | |
| Normalized Basic EPS | 2,080.91% | -- | -- | -- | |
| EPS Diluted | 1,584.85% | -- | -- | -- | |
| Normalized Diluted EPS | 2,080.91% | -- | -- | -- | |
| Average Basic Shares Outstanding | 104.92% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 204.92% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -0.65% | -- | -- | -- | |